Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 8, 2023Conzerol zero molluscum contagiosumCGMP deviationsDiscovery Pharma LLC · D-0261-2023Class IITerminatedFeb 8, 2023Global Care 70% Alcohol Ethyl Rubbing AlcoholcGMP DeviationsFrenda Corporation · D-0260-2023Class IITerminatedFeb 8, 2023Global Care Antibacterial Hand Sanitizer Alcohol Etilico 70% OriginalcGMP DeviationsFrenda Corporation · D-0259-2023Class IITerminatedFeb 8, 2023Easy Clean 75% Ethyl AlcoholcGMP DeviationsFrenda Corporation · D-0258-2023Class IITerminatedFeb 8, 2023Easy Clean 70% Isopropyl AlcoholcGMP DeviationsFrenda Corporation · D-0257-2023Class IITerminatedFeb 8, 2023Easy Clean Isopropyl Alcohol 99%cGMP DeviationsFrenda Corporation · D-0256-2023Class IITerminatedFeb 8, 2023Easy Clean Alcohol Mult Surface Disinfecting Cleaner 75% Ethyl AlcoholcGMP DeviationsFrenda Corporation · D-0255-2023Class IITerminatedFeb 8, 2023Easy Clean Antiseptic Hand Sanitizer Solution 65% with GlycerinecGMP DeviationsFrenda Corporation · D-0254-2023Class ITerminatedFeb 8, 2023Easy Care First Aid 10 Person 2009 ANSIMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0253-2023Class ITerminatedFeb 8, 2023CVS First Aid HomeMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0252-2023Class ITerminatedFeb 8, 2023Easy Care First Aid 25 Person 2009 ANSIMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0251-2023Class ITerminatedFeb 8, 2023Easy Care First Aid Class A ANSI 25 PersonMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0250-2023Class ITerminatedFeb 8, 2023Easy Care First Aid 10 Person 2009 ANSIMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0249-2023Class ITerminatedFeb 8, 2023Easy Care First Aid 25 Person 2009 ANSIMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0248-2023Class ITerminatedFeb 8, 2023Adventure First Aid 1.5Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0247-2023Class ITerminatedFeb 8, 2023Adventure First Aid 1.0Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0246-2023Class ITerminatedFeb 8, 2023Adventure Marine 150Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0245-2023Class ITerminatedFeb 8, 2023Easy Care first aid Burn CreamMicrobial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.GFA Production Xiamen Co. Ltd. · D-0244-2023Class IITerminatedFeb 1, 2023VORICONAZOLE 10MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0243-2023Class IITerminatedFeb 1, 2023VITAMIN D3-AQUEOUS- 10Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0242-2023Class IITerminatedFeb 1, 2023VANCOMYCIN FORTIFIED 10MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0241-2023Class IITerminatedFeb 1, 2023TOBRAMYCIN FORTIFIED 15MG/ML OPH SOLUTIONLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0240-2023Class IITerminatedFeb 1, 2023THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0239-2023Class IITerminatedFeb 1, 2023TESTOSTERONE 3%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0238-2023Class IITerminatedFeb 1, 2023TACROLIMUS 0.03% OPH SOLUTION TACROLIMUS 0.1%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0237-2023Class IITerminatedFeb 1, 2023SEMAGLUTIDE 0.5MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0236-2023Class IITerminatedFeb 1, 2023SCOPOLAMINE HYDROBROMIDE 0.25% OPH SOLUTIONLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0235-2023Class IITerminatedFeb 1, 2023PROSTAGLANDINLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0234-2023Class IITerminatedFeb 1, 2023PROGESTERONE-GS OIL- 100MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0233-2023Class IITerminatedFeb 1, 2023POLYHEXAMETHYLENE BIGUANIDE 0.2MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0232-2023Class IITerminatedFeb 1, 2023POLIDOCANOL 50MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0231-2023Class IITerminatedFeb 1, 2023PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACIDLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0230-2023Class IITerminatedFeb 1, 2023PHENOL 10%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0229-2023Class IITerminatedFeb 1, 2023PE1/PAPAV/PHEN 20MCG/30MG/2MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0228-2023Class IITerminatedFeb 1, 2023PE1/PAPAV/ATROP/CHLOPROM** 7MCG/8.7MG/0.1MG/1.8MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0227-2023Class IITerminatedFeb 1, 2023PAPAVERINE/PHENTOLAMINE 30MG/0.5MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0226-2023Class IITerminatedFeb 1, 2023NADH 10MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0225-2023Class IITerminatedFeb 1, 2023MITOMYCIN 0.4MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0224-2023Class IITerminatedFeb 1, 2023MITOMYCIN 0.2MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0223-2023Class IITerminatedFeb 1, 2023METHYLCOBALAMIN 12.5MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0222-2023